-
Mashup Score: 35Overall Survival of Metastatic Prostate Cancer Patients According to Location of Visceral Metastatic Sites - 2 year(s) ago
It is unknown whether specific locations of visceral metastatic sites affect overall survival (OS) of metastatic prostate cancer (mPCa) patients. We t…
Tweet
-
Mashup Score: 19
Our novel and straightforward risk classification integrates currently available preoperative risk tools and should, therefore, assist physician in preoperative counseling of men candidates for radical treatment for prostate cancer with positive lymph node uptake at prostate-specific membrane antige …
Tweet-
Thinking about how pre operative PSMA PET/CT imaging impacts long term outcomes
-
-
Mashup Score: 11
Radium-223 (Ra233) prolongs the survival of men with symptomatic bone-predominant metastatic castration-resistant prostate cancer (mCRPC). However, prostate-specific antigen (PSA) response patterns are not closely associated with Ra223 therapy outcomes. Herein, we sought to analyze the impact of Ra2 …
Tweet-
Interesting article on PSA rises seen during radium-223 treatment.
-
-
Mashup Score: 45Treatment patterns and outcomes in older adults with castration-resistant prostate cancer: Analysis of an Australian real-world cohort - 2 year(s) ago
Prostate cancer (PC) is the second commonest malignancy and fifth leading cause of cancer death in men worldwide. Older men are more likely to develop…
Tweet-
Lastly, data from Australia on the treatment patters of older adults with metastatic castration resistant prostate cancer.
-
Helpful to share with patients and matches what I've seen and has been previously published - not all "visceral mets" are the same and the lung only group tends to have better outcomes.